➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKesson
McKinsey
Express Scripts
Dow

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Corden Pharma Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CORDEN PHARMA, and what generic and branded alternatives to CORDEN PHARMA drugs are available?

CORDEN PHARMA has five approved drugs.



Summary for Corden Pharma
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Corden Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-001 Dec 23, 1991 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-001 Approved Prior to Jan 1, 1982 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-002 Approved Prior to Jan 1, 1982 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma CEFZIL cefprozil TABLET;ORAL 050664-002 Dec 23, 1991 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Corden Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 4,657,927*PED ⤷  Free Forever Trial
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 4,657,927*PED ⤷  Free Forever Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 3,524,844 ⤷  Free Forever Trial
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 4,657,927*PED ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Merck
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.